Zolpidem: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Zolpidem. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 7% |
| Allergy | 4% |
| Sinusitis | 4% |
| Dry mouth | 3% |
| Back pain | 3% |
| Lethargy | 3% |
| Drugged feeling | 3% |
| Pharyngitis | 3% |
| Drowsiness | 2% |
| Influenza-like symptoms | 2% |
| Palpitation | 2% |
| Lightheadedness | 2% |
| Depression | 2% |
| Abdominal pain | 2% |
| Constipation | 2% |
| Rash | 2% |
| Dizziness | 1% |
| Diarrhea | 1% |
| Chest pain | 1% |
| Abnormal dreams | 1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
1 INDICATIONS AND USAGE Zolpidem tartrate tablets, USP are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets, USP have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [ see CLINICAL STUDIES (14)] . The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.